TABLE 1.
Target organ | No. of studies | False positive rate (per 100) | Prevalence (per 1000) | Positive Predictive Value (per 100) |
---|---|---|---|---|
Renal | ||||
Screening | 6 | 1.0 | 0.6 | 1.5 |
Non-screening | 13 | 1.0 | 4.2 | 25.0 |
Mixed/Unknown | 3 | - | - | - |
Overall | 22 | 1.1 | 2.2 | 20.5 |
Lung | ||||
Screening | 6 | 0.2 | 0.1 | 20.0 |
Non-screening | 6 | 0.7 | 0.7 | 0 |
Mixed/Unknown | 3 | - | - | - |
Overall | 15 | 0.7 | 0.1 | 3.8 |
Liver | ||||
Screening | 4 | 0 | 1.2 | 0 |
Non-screening | 8 | 1.8 | 0 | 0 |
Mixed/Unknown | 2 | - | - | - |
Overall | 14 | 1.3 | 0 | 0 |
Pancreas | ||||
Screening | 2 | 0.1 | 0 | 0 |
Non-screening | 5 | 1.4 | 1.2 | 25.0 |
Mixed/Unknown | 1 | - | - | - |
Overall | 8 | 0.5 | 0.5 | 0 |
Ovary | ||||
Screening | 5 | 1.5 | 0 | 0 |
Non-screening | 9 | 3.7 | 0 | 10.0 |
Mixed/Unknown | 1 | - | - | - |
Overall | 15 | 2.5 | 0 | 0 |
Summarized across studies with available data for the calculation.
- cannot be calculated due to missing data on the number of true positive results.